As part of a close working relationship between EURO-NMD and RD-Connect we are delighted to announce a series of highly relevant and informative webinars for any researchers who are involved in an ERN.

RD-Connect enables scientists and clinicians around the world to analyse genomics data and share them with other researchers.

By making data accessible beyond the usual institutional and national boundaries, RD-Connect speeds up research, diagnosis and therapy development to improve the lives of patients with rare diseases.


RD-Connect, a platform connecting rare disease researchers worldwide

RD-Connect is an EU-funded integrated platform connecting databases, registries, biobanks and clinical bioinformatics for rare disease research. To help researchers study rare diseases, RD-Connect links different data types – omics (e.g. genomics), clinical information, patient registries and biobanks – into a common resource. By enabling scientists and clinicians around the world to analyse and share data and share, RD-Connect speeds up research, diagnosis and therapy development to improve the lives of patients with rare diseases.

RD-Connect has built three integrated online systems open to any rare disease:



RD-Connect is open for data submissions and already holds thousands of secure, pseudonymised datasets, including linked omics and phenotypic data, biosamples and information about rare disease patient registries and biobanks. Data are linked at an individual per-patient or per-sample level. Researchers can analyse data, find similar cases and related information such as availability of biomaterials. In collaborations with several projects, RD-Connect has already contributed to the discovery of dozens of novel disease genes.


Watch the RD-Connect Introductory Video

Opportunities for ERN clinicians to use RD-Connect tools

RD-Connect is working together with the ERNs to support them in their research and diagnostic goals. In particular, the RD-Connect Genome-Phenome Analysis Platform can be used by the ERN clinicians themselves to solve their unsolved cases. In 2018 and 2019, as part of the Solve-RD project, the RD-Connect Genome-Phenome Analysis Platform will be used by clinicians and researchers from four ERNs for reanalysis of 19,000 undiagnosed exomes towards diagnosis and gene discovery. GENTURIS, EURO-NMD, ITHACA, and ERN-RND are full partners in Solve-RD, with six more ERNs as associated partners. However, all ERNs are invited to submit their sequencing data and analyse them in RD-Connect, so if you have a cohort of undiagnosed patients with NGS data you would like support in reanalysing, we would love to hear from you!



Webinars

Together with the ERN EURO-NMD, RD-Connect is organising a series of webinars aiming to train ERN members at all levels. The webinars will let you learn how the RD-Connect tools can help you in your everyday work.

If you are interested in any of the webinars below, please register with your email address to be sent the final details and a link to access the webinar. Registration is non-binding but allows us to send you the details and helps us estimate the number of attendees. Precise times for the webinars will be confirmed later in August on the RD-Connect website and to everyone who registers via the link below.


Genomic analysis quick and easy: RD-Connect Genome-Phenome Analysis Platform

Steven Laurie, Centro Nacional de Análisis Genómico, Barcelona, Spain

Thursday 6th September 2018, 15:00 CEST

Register your interest here

In this webinar, you will learn how to use the powerful and user-friendly analysis tools in the GPAP to interpret, filter and prioritise your variants to identify disease-causing mutations and help diagnose your rare disease patients. The system also allows you to compare your data with data submitted by other members of the RD-Connect community, and further afield, to find confirmatory cases for your candidate variants.


Finding registries and biosamples in just a few clicks: RD-Connect Registry & Biobank Finder and Sample Catalogue

Mary Wang, Fondazione Telethon, Milan, Italy

Tuesday 18 September 2018, 15:00 CEST

Register your interest here

This webinar will demonstrate how to use two tools that will help you quickly identify patient registries in Europe and beyond that hold data on your disease of interest. They also let you find rare disease biobanks and browse their sample collections, with detailed information about each individual sample.


Linking up all those data: why should we make data FAIR

Marco Roos, Leiden University Medical Center, The Netherlands

Date: tbc

Register your interest here

The webinar will explain what makes data Findable, Accessible, Interoperable and Reusable (FAIR) and why it is critical that different types of information, such as medical records, clinical and phenotypic data, test results, sequencing data and biosample details are made FAIR at the source.


If you are interested in any of the above webinars, please register and you will receive the link to the webinar by email closer to the date. Please register here.

Register for webinars here


RD-Connect Community

Join the RD-Connect Community

In July 2018 the new RD-Connect Community was launched. This is an international association of individuals and organizations who would like to participate in shaping the rare disease field, promote data sharing and reuse and advance research. Membership is free of charge and open to organisations, research groups and individuals from diverse backgrounds, engaged in rare disease research anywhere in the world. Several ERNs have signed up as members, but we would be delighted to receive registrations from individual healthcare professionals HCPs and research groups.

Interested in joining? Fill out the registration form to become a member! For more information about the RD-Connect Community, please click here.

Find out more about the RD-Connect Community.

Interested in joining? Fill out the registration form to become a member!

The ERNs are co-funded by the
European Union (Health Programme and CEF)

EU Commission


“EURO-NMD is one of the 24 European Reference Networks (ERNs) approved by the ERN Board of Member States. The ERNs are co-funded by the European Union (Health Programme and CEF).
For more information about the ERNs and the EU health strategy,
please visit ec.europa.eu/health/ern